MétaCan
Menu
Back to cohort
Record W4390629233 · doi:10.1212/wnl.0000000000208008

Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium

2024· article· en· W4390629233 on OpenAlexfundno aff
Parichita Choudhury, Joyce Lee‐Iannotti, Andrea Busicescu, Pooja Rangan, Maria Livia Fantini, Alon Y. Avidan, Donald L. Bliwise, Susan R. Criswell, Emmanuel During, Jonathan E. Elliott, Julie A. Fields, Jean‐François Gagnon, Michael J. Howell, Daniel E. Huddleston, Jennifer McLeland, Emmanuel Mignot, Mitchell G. Miglis, Miranda M. Lim, Amélie Pelletier, Carlos H. Schenck, David Shprecher, Erik K. St. Louis, Aleksandar Videnović, Yo‐El S. Ju, Bradley F. Boeve, Ronald B. Postuma, Sommer Amudson-Huffmaster, Anam J. Arik, Nellie Brushaber, Jae Woo Chung, Joshua De Kam, Adrian Ekelmans, Marissa Keane, Allison Keil, Ruth Kraft, Brittany R. Ligman, Colum D. MacKinnon, Daeva Miner-Rose, Samantha Murphy, Cosette Olivo, Katherine L.M. Powers, Adreanne Rivera, Sarahmay Sanchez, Matthew Stauder, Rebekah L. S. Summers, Luke Tiegan, Paul Timm, Kelsey Tucker, Peter Tran

Bibliographic record

VenueNeurology · 2024
Typearticle
Languageen
FieldNeuroscience
TopicSleep and Wakefulness Research
Canadian institutionsnot available
FundersPacific Northwest National LaboratoryNational Institute of Neurological Disorders and StrokeNational Institute of Mental HealthNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthNational Institute on AgingRespicardiaNational Institutes of HealthPortland VA Research FoundationIdorsia PharmaceuticalsNational Alliance for Research on Schizophrenia and DepressionNational Science FoundationGeorgia Research AllianceEmory UniversityU.S. Department of Veterans AffairsAlexion PharmaceuticalsPfizerBiogenU.S. Department of DefenseSanofiAmerican Sleep Medicine FoundationAustralian GovernmentDemensförbundetEisaiCanadian Institutes of Health ResearchJazz PharmaceuticalsCollins Medical TrustNational Institute of General Medical SciencesSunovionAmerican Heart AssociationNational Center for Advancing Translational SciencesTeva Pharmaceutical Industries
KeywordsScale (ratio)MedicineGerontologyPsychologyGeographyCartography

Abstract

fetched live from OpenAlex

Background and ObjectivesREM sleep behavior disorder (RBD) is a parasomnia characterized by dream enactment. The International RBD Study Group developed the RBD Symptom Severity Scale (RBDSSS) to assess symptom severity for clinical or research use. We assessed the psychometric and clinimetric properties of the RBDSSS in participants enrolled in the North American Prodromal Synucleinopathy (NAPS) Consortium for RBD. MethodsNAPS participants, who have polysomnogram-confirmed RBD, and their bedpartners completed the RBDSSS (participant and bedpartner versions). The RBDSSS contains 8 questions to assess the frequency and severity/impact of (1) dream content, (2) vocalizations, (3) movements, and (4) injuries associated with RBD. Total scores for participant (maximum score = 54) and bedpartner (maximum score = 38) questionnaires were derived by multiplying frequency and severity scores for each question. The Clinical Global Impression Scale of Severity (CGI-S) and RBD symptom frequency were assessed by a physician during a semistructured clinical interview with participants and, if available, bedpartners. Descriptive analyses, correlations between overall scores, and subitems were assessed, and item response analysis was performed to determine the scale's validity. ResultsAmong 261 study participants, the median (interquartile range) score for the RBDSSS-PT (participant) was 10 (4–18) and that for the RBDSSS-BP (bedpartner) was 8 (4–15). The median CGI-S was 3 (3–4), indicating moderate severity. RBDSSS-BP scores were significantly lower in women with RBD (6 vs 9, p = 0.02), while there were no sex differences in RBDSSS-PT scores (8 vs 10.5, p = 0.615). Positive correlations were found between RBDSSS-PT vs RBDSSS-BP (Spearman rs = 0.561), RBDSSS-PT vs CGI-S (rs = 0.556), and RBDSSS-BP vs CGI-S (rs = 0.491, all p < 0.0001). Item response analysis showed a high discriminatory value (range 1.40–2.12) for the RBDSSS-PT and RBDSSS-BP (1.29–3.47). DiscussionWe describe the RBDSSS with adequate psychometric and clinimetric properties to quantify RBD symptom severity and good concordance between participant and bedpartner questionnaires and between RBDSSS scores and clinician-assessed global severity.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.065

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.019
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.278
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueNeurologySame topicSleep and Wakefulness ResearchFrench-language works237,207